PL353343A1 - Use of thienopyrimidines - Google Patents

Use of thienopyrimidines

Info

Publication number
PL353343A1
PL353343A1 PL00353343A PL35334300A PL353343A1 PL 353343 A1 PL353343 A1 PL 353343A1 PL 00353343 A PL00353343 A PL 00353343A PL 35334300 A PL35334300 A PL 35334300A PL 353343 A1 PL353343 A1 PL 353343A1
Authority
PL
Poland
Prior art keywords
thienopyrimidines
Prior art date
Application number
PL00353343A
Other languages
English (en)
Polish (pl)
Inventor
Rochus Jonas
Volker Eiermann
Sabine Bernotat-Danielowski
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL353343A1 publication Critical patent/PL353343A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL00353343A 1999-09-14 2000-08-24 Use of thienopyrimidines PL353343A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19943815A DE19943815A1 (de) 1999-09-14 1999-09-14 Verwendung von Thienopyrimidinen
PCT/EP2000/008258 WO2001019369A1 (fr) 1999-09-14 2000-08-24 Utilisation de thiénopyrimidines

Publications (1)

Publication Number Publication Date
PL353343A1 true PL353343A1 (en) 2003-11-17

Family

ID=7921854

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00353343A PL353343A1 (en) 1999-09-14 2000-08-24 Use of thienopyrimidines

Country Status (18)

Country Link
EP (1) EP1212062A1 (fr)
JP (1) JP2003509370A (fr)
KR (1) KR20020026011A (fr)
CN (1) CN1377271A (fr)
AR (1) AR025645A1 (fr)
AU (1) AU6703200A (fr)
BR (1) BR0013957A (fr)
CA (1) CA2387123A1 (fr)
CZ (1) CZ2002818A3 (fr)
DE (1) DE19943815A1 (fr)
HU (1) HUP0202614A3 (fr)
MX (1) MXPA02002746A (fr)
NO (1) NO20021234L (fr)
PL (1) PL353343A1 (fr)
RU (1) RU2002107441A (fr)
SK (1) SK3322002A3 (fr)
WO (1) WO2001019369A1 (fr)
ZA (1) ZA200202868B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002226362A1 (en) * 2000-12-19 2002-07-01 Merck Patent Gmbh Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2)
DE10135815A1 (de) * 2001-07-23 2003-02-06 Bayer Ag Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869486A (en) * 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
IL126351A0 (en) * 1996-04-12 1999-05-09 Warner Lambert Co Irreversible inhibitors of tyrosine kinases
DE19644228A1 (de) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
DE19819023A1 (de) * 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidine
US5948911A (en) * 1998-11-20 1999-09-07 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to thienopyrimidine derivatives
CN1346358A (zh) * 1999-03-30 2002-04-24 日本曹达株式会社 噻吩并嘧啶化合物及其盐和制备方法

Also Published As

Publication number Publication date
CZ2002818A3 (cs) 2002-06-12
SK3322002A3 (en) 2002-07-02
NO20021234D0 (no) 2002-03-13
CN1377271A (zh) 2002-10-30
MXPA02002746A (es) 2002-10-23
WO2001019369A1 (fr) 2001-03-22
AU6703200A (en) 2001-04-17
BR0013957A (pt) 2002-05-21
HUP0202614A3 (en) 2004-11-29
CA2387123A1 (fr) 2001-03-22
HUP0202614A2 (hu) 2002-12-28
AR025645A1 (es) 2002-12-04
ZA200202868B (en) 2003-11-26
DE19943815A1 (de) 2001-03-15
KR20020026011A (ko) 2002-04-04
EP1212062A1 (fr) 2002-06-12
NO20021234L (no) 2002-03-13
JP2003509370A (ja) 2003-03-11
RU2002107441A (ru) 2003-11-20

Similar Documents

Publication Publication Date Title
PL361277A1 (en) Use of thienopyrimidines
PL355101A1 (en) Use of h1
GB9913536D0 (en) Use
PL351822A1 (en) Thienopyrimidines as phosphodiesterase inhibitors
GB9900227D0 (en) Use of a composition
AU141671S (en) Set of containers
EG22530A (en) Preparation of substituted piperidin-4-ones
EP1218407A4 (fr) Utilisation de la kappa-conotoxine pviia
PL352409A1 (en) Derivatives of 1-trifluorometyl-4-hydroxy-7-piperidinyl-aminomethylochromane
GB9925634D0 (en) Modification of plants
PL350963A1 (en) Use of arylalkanoylpyridazines
HUP0202614A3 (en) Use of thienopyrimidines
GB9919971D0 (en) Use
GB9910667D0 (en) New use of citreamicins
GB0210548D0 (en) Measurement of objects
EP1230928A4 (fr) Utilisation de peptide
HU9900075V0 (en) Sepulchre consists of elements
TW422400U (en) Improvement of transformer
GB9925382D0 (en) Preparation of sulphides
TW394123U (en) Structure of emery-roller
TW468411U (en) Structure of cardcase
GB9920641D0 (en) Gnosis - The game of understanding
TW399438U (en) Improved structure of bedhead
TW389046U (en) Structure of hairgrip combinations
TW395176U (en) Structure of designed article